Clin2
NCT05848310Possibly a fitRecruiting

Blood test before surgery to predict biliary atresia outcome

Biliary AtresiaPrognosis

Part of Digestive system, Genetic & congenital clinical trials.

This study looks at a specific pre-surgery blood marker called FGF19 (and related liver blood tests) in children with biliary atresia. The goal is to see whether the blood results before surgery can help predict how well children recover after surgery.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
200 people
Ages
Any age
Study type
Observational

Who can take part

  • Your child has been diagnosed with biliary atresia at Children’s Hospital of Fudan University
  • There is a record of follow-up for your child about 1 year after surgery
  • There are lab results for total bilirubin (a liver-related blood test) about 3 months after surgery
  • A stored pre-surgery blood sample is available and has enough volume (more than 500 microliters)
  • There are no listed exclusion conditions for this study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04272515Recruiting
Learn from tissue or samples from biliary atresia patients

This study looks to better understand biliary atresia by studying patient information and/or samples. It may help researchers learn why the condition happens and how to improve care.

Paris, De
NCT03273049Recruiting
Study of disease processes in children getting liver transplants

This study maps how biliary atresia (a childhood blockage/problem with bile flow from the liver) progresses and changes in the body around the time of a liver transplant. It may help doctors better understand the disease and improve future care.

Pittsburgh, Pennsylvania
NCT00345553Recruiting
Study for children with biliary atresia

This study enrolls children and young adults with biliary atresia (a condition where bile can’t flow properly from the liver) to learn from their care and outcomes over scheduled visits. It may help researchers understand the disease better and improve future treatment.

Los Angeles, California
NCT06708572Recruiting
GCSF after Kasai surgery for biliary atresia

This study tests a medicine called GCSF (helps make white blood cells) in babies who have had Kasai surgery for biliary atresia. It aims to see if GCSF can improve liver function and overall outcomes.

Cairo, Menofia Governorate
NCT00061828Recruiting
Tracking Liver Disease in Newborns and Young Infants

This study follows babies under 6 months old who have early signs of liver disease (cholestasis) to better understand what causes it and how it progresses. Researchers will collect medical information over time to improve diagnosis and treatment.

Los Angeles, California
NCT06764082Recruiting
Nutrition study for babies with biliary atresia

This study tests whether a special nutrition plan helps babies with biliary atresia recover better after Kasai surgery. It is for infants under 3 months old who are ready for surgery.

Wuhan, Hubei

Hear when a new Biliary Atresia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.